RayzeBio, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: RayzeBio, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q3 2023.
RayzeBio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $8.48M.

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2023	$8.48M			Sep 30, 2023	10-Q	2023-11-13
Q4 2022	$9.31M			Dec 31, 2022	10-Q	2023-11-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.